Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Glaukos Corporation - SIC # 3840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
GKOS
New York
3840
www.glaukos.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Glaukos Corporation
iShares Russell 2000 (IWM) Buys $1.9 Million More Jackson Financial on Nov. 2
- Nov 4th, 2026 4:04 am
Glaukos (GKOS) Joins The S&P 400, Is It Overvalued At Current Levels?
- Nov 3rd, 2026 8:15 pm
McGrath RentCorp Soars 9% as It Prepares to Join the S&P SmallCap 600
- Nov 3rd, 2026 10:33 am
BDX Gears Up to Report Q4 Results: How to Play the Stock?
- Nov 3rd, 2026 10:06 am
Will MCK's Pharma & Specialty Demand Offset Pricing Headwind in Q2?
- Nov 3rd, 2026 6:15 am
Glaukos Announces Participation in Upcoming Investor Conferences
- Nov 3rd, 2026 5:00 am
SOLV's Q3 Earnings: Can Growth Momentum Offset ERP-Related Headwinds?
- Nov 2nd, 2026 8:49 am
Kenvue Is Leaving the S&P 500: Here’s What It Means for Investors
- Nov 2nd, 2026 8:47 am
Okta Stock Rises Ahead of S&P 500 Entry
- Nov 2nd, 2026 7:29 am
Can CAH's Specialty Strength Offset Medical Distribution Challenges in Q1?
- Nov 2nd, 2026 4:42 am
Okta Stock Can Find More Buyers as It Joins the S&P 500
- Nov 2nd, 2026 4:21 am
iShares Russell 2000 (IWM) Adds Jackson Financial, Trims Glaukos on Thursday
- Nov 2nd, 2026 4:05 am
Okta Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
- Oct 30th, 2026 3:51 pm
SYK Stock Skids as Q3 Earnings and Sales Miss & 2026 Outlook Cut
- Oct 30th, 2026 11:56 am
Glaukos (GKOS) Earnings, Outlook ‘Brighter’; Shares Soar to All-Time High
- Oct 29th, 2026 7:58 pm
Glaukos (GKOS) Stock Charges Higher On Q3 Earnings Surprise
- Oct 29th, 2026 6:15 pm
Glaukos Sets $1 Billion 2027 Sales Goal: Rapid Earnings Reaction
- Oct 29th, 2026 1:50 pm
Why Glaukos Stock Is Surging 30% and Headed for Record Close After Earnings
- Oct 29th, 2026 9:57 am
West Pharma Q3 Earnings Rise on HVP Strength, 2026 Outlook Raised
- Oct 29th, 2026 9:04 am
Glaukos Soars 26% on “Exceptional” Quarter and $1 Billion 2027 Sales Outlook
- Oct 29th, 2026 8:18 am
Scroll